1. Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan
- Author
-
Teng, Chung-Jen, Huon, Leh-Kiong, Hu, Yu-Wen, Yeh, Chiu-Mei, Chao, Yee, Yang, Muh-Hwa, Chen, Tzeng-Ji, Hung, Yi-Ping, and Liu, Chia-Jen
- Subjects
Patient Safety ,Health Services ,Cervical Cancer ,Cancer ,Clinical Research ,Adult ,Aged ,Antineoplastic Agents ,Carboplatin ,Comorbidity ,Female ,Fluorouracil ,Humans ,Middle Aged ,Neoplasms ,Second Primary ,Radiotherapy ,Registries ,Taiwan ,Uterine Cervical Neoplasms ,Young Adult ,Clinical Sciences ,Arthritis & Rheumatology - Abstract
To evaluate the risk of secondary primary malignancy (SPM) in patients with cervical cancer using a nationwide population-based dataset.Patients newly diagnosed with cervical cancer between 1997 and 2011 were identified using Taiwan's National Health Insurance database. Patients with antecedent malignancies were excluded. Standardized incidence ratios (SIRs) for SPM were calculated by comparing with the cancer incidence in the general population. Risk factors for cancer development were analyzed using Cox proportional hazard models.During the 14-year study period (follow-up of 223,062 person-years), 2004 cancers developed in 35,175 patients with cervical cancer. The SIR for all cancers was 1.56 (95% confidence interval, 1.50-1.63, P 10, 5 to 10, 1 to 5, and
- Published
- 2015